Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older
Article in Expert Review of Vaccines (November 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Expert Review of Vaccines (November 2023)
Book chapter (January 2023)
Article in Environment and Planning B Urban Analytics and City Science (December 2022)